Search results for CD41

CD41 antibody (MEM-06), Covalab, Ref 00113332

CD41 antibody (MWReg30) [PE], Covalab, Ref 00114669

APC anti-human CD41/CD61 Antibody anti-CD41/CD61 - A2A9/6, BioLegend, 359807

Additional reported applications (for relevant formats) include: immunoprecipitation1and blocking (aggregation)2. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 359804).A2A9/6 is recognized as having high affinity to gpIIb/IIIa. It has been shown to inhibit platelet aggregation induced by a variety of agonists and the initiation of clot formation.

APC anti-human CD41/CD61 Antibody anti-CD41/CD61 - A2A9/6, BioLegend, 359808

Additional reported applications (for relevant formats) include: immunoprecipitation1and blocking (aggregation)2. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 359804).A2A9/6 is recognized as having high affinity to gpIIb/IIIa. It has been shown to inhibit platelet aggregation induced by a variety of agonists and the initiation of clot formation.

FITC anti-human CD41/CD61 Antibody anti-CD41/CD61 - A2A9/6, BioLegend, 359809

Additional reported applications (for relevant formats) include: immunoprecipitation1and blocking (aggregation)2. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 359804).A2A9/6 is recognized as having high affinity to gpIIb/IIIa. It has been shown to inhibit platelet aggregation induced by a variety of agonists and the initiation of clot formation.

FITC anti-human CD41/CD61 Antibody anti-CD41/CD61 - A2A9/6, BioLegend, 359810

Additional reported applications (for relevant formats) include: immunoprecipitation1and blocking (aggregation)2. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 359804).A2A9/6 is recognized as having high affinity to gpIIb/IIIa. It has been shown to inhibit platelet aggregation induced by a variety of agonists and the initiation of clot formation.

PE anti-human CD41/CD61 Antibody anti-CD41/CD61 - A2A9/6, BioLegend, 359805

Additional reported applications (for relevant formats) include: immunoprecipitation1and blocking (aggregation)2. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 359804).A2A9/6 is recognized as having high affinity to gpIIb/IIIa. It has been shown to inhibit platelet aggregation induced by a variety of agonists and the initiation of clot formation.

PE anti-human CD41/CD61 Antibody anti-CD41/CD61 - A2A9/6, BioLegend, 359806

Additional reported applications (for relevant formats) include: immunoprecipitation1and blocking (aggregation)2. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 359804).A2A9/6 is recognized as having high affinity to gpIIb/IIIa. It has been shown to inhibit platelet aggregation induced by a variety of agonists and the initiation of clot formation.

Purified anti-human CD41/CD61 Antibody anti-CD41/CD61 - A2A9/6, BioLegend, 359802

Additional reported applications (for relevant formats) include: immunoprecipitation1and blocking (aggregation)2. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 359804).A2A9/6 is recognized as having high affinity to gpIIb/IIIa. It has been shown to inhibit platelet aggregation induced by a variety of agonists and the initiation of clot formation.

FITC anti-human CD41/CD61 Antibody anti-CD41/CD61 - PAC-1, BioLegend, 362803

Additional reported applications (for the relevant formats of this clone) include: immunoprecipitation1,2, Western blotting2andin vitroblocking of platelet aggregation2.The PAC-1 antibody reacts with activation-induced conformational epitope of the integrin aIIbß3.PAC-1 binding to fibrinogen is pH and Ca2+dependent, and will not bind to platelets that have been fixed. We recommend staining in buffers free of Ethylenediaminetetraacetic acid (EDTA) at a pH of 6.5 or higher. Sodium citrate may be used as an anticoagulant for blood collection3.